Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I TrialElizabeth C. Kent, David C. Smith, Howard M. Sandler et al.|Journal of Clinical Oncology|2004Cited by 86
ACR Appropriateness Criteria ® Pretreatment Staging of Colorectal CancerKathryn J. Fowler, Laura R. Carucci, Harmeet Kaur et al.|Journal of the American College of Radiology|2017Cited by 82
A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal CarcinomatosisKim A. Reiss, Nilofer S. Azad, Joseph M. Herman et al.|Clinical Cancer Research|2014Cited by 75
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A. Reiss, Nilofer S. Azad, Joseph M. Herman et al.|Gynecologic Oncology|2017Cited by 53
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the PancreasLeila T. Tchelebi, Joseph M. Herman, Diana Segovia et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 31